$2.31
2.16%
Downside
Day's Volatility :7.38%
Upside
5.33%
54.11%
Downside
52 Weeks Volatility :68.73%
Upside
31.84%
Period | Heartbeam Inc | Index (Russel 2000) |
---|---|---|
3 Months | -4.55% | 0.0% |
6 Months | 12.68% | 0.0% |
1 Year | 14.93% | 0.0% |
3 Years | -50.75% | -22.3% |
Market Capitalization | 61.4M |
Book Value | $0.33 |
Earnings Per Share (EPS) | -0.56 |
Wall Street Target Price | 5.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -69.75% |
Return On Equity TTM | -113.62% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -0.56 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.71 |
EPS Estimate Next Year | -0.53 |
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Next Quarter | -0.16 |
What analysts predicted
Upside of 116.45%
Sell
Neutral
Buy
Heartbeam Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Heartbeam Inc | 2.21% | 12.68% | 14.93% | -50.75% | -94.2% |
![]() Solventum Corp | 18.43% | -4.2% | -4.2% | -4.2% | -4.2% |
![]() Doximity, Inc. | 42.51% | 26.66% | 54.18% | -63.01% | -31.43% |
![]() Veeva Systems Inc. | 18.46% | -6.2% | -2.75% | -30.3% | 49.39% |
![]() Ge Healthcare Technologies Inc. | 7.25% | -8.17% | 29.12% | 40.67% | 40.67% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Heartbeam Inc | NA | NA | NA | -0.71 | -1.14 | -0.7 | NA | 0.33 |
![]() Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
![]() Doximity, Inc. | 45.43 | 45.43 | 2.42 | 0.9 | 0.17 | 0.11 | NA | 4.92 |
![]() Veeva Systems Inc. | 57.42 | 57.42 | 1.39 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
![]() Ge Healthcare Technologies Inc. | 25.23 | 25.23 | 2.26 | 4.24 | 0.21 | 0.06 | 0.0 | 17.08 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Heartbeam Inc | Buy | $61.4M | -94.2% | NA | 0.0% |
![]() Solventum Corp | Hold | $10.8B | -4.2% | NA | 15.73% |
![]() Doximity, Inc. | Hold | $6.7B | -31.43% | 45.43 | 32.53% |
![]() Veeva Systems Inc. | Buy | $35.0B | 49.39% | 57.42 | 23.91% |
![]() Ge Healthcare Technologies Inc. | Buy | $39.9B | 40.67% | 25.23 | 8.1% |
Insights on Heartbeam Inc
In the last 1 year, Doximity, Inc. has given 54.2% return, outperforming this stock by 39.3%
Vanguard Group Inc
Smith, Salley & Associates, LLC
Geode Capital Management, LLC
UBS Group AG
Beacon Pointe Advisors, LLC
Spectrum Asset Management Inc
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
Organization | Heartbeam Inc |
Employees | 15 |
CEO | Mr. Richard M. Ferrari |
Industry | Health Technology |
A Spac I Acquisition Corp
$2.31
-6.48%
Keyarch Acquisition Corp
$2.31
-6.48%
Connexa Sports Technologies Inc
$2.31
-6.48%
Us Value Etf
$2.31
-6.48%
First Wave Biopharma Inc
$2.31
-6.48%
Global X Msci Next Emerging
$2.31
-6.48%
Fat Projects Acquisition Corp
$2.31
-6.48%
Capital Link Global Fintech
$2.31
-6.48%
Applied Uv Inc
$2.31
-6.48%